Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea
· Delayed Price · Currency is KRW 42,800
-500 (-1.15%)
Mar 9, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Revenue
Anterogen.Co.,Ltd. had revenue of 2.04B KRW in the quarter ending September 30, 2025, with 7.39% growth. This brings the company's revenue in the last twelve months to 7.32B, up 5.30% year-over-year. In the year 2024, Anterogen.Co.,Ltd. had annual revenue of 6.93B with 6.66% growth.
Revenue (ttm)
7.32B
Revenue Growth
+5.30%
P/S Ratio
58.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
428.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.93B | 432.62M | 6.66% |
| Dec 31, 2023 | 6.50B | -90.76M | -1.38% |
| Dec 31, 2022 | 6.59B | -1.53B | -18.85% |
| Dec 31, 2021 | 8.12B | 3.97B | 95.64% |
| Dec 31, 2020 | 4.15B | 3.67M | 0.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BINEX | 165.64B |
| Genomictree | 3.76B |
| SillaJen | 7.84B |
| GC Cell | 170.13B |
| Bioneer | 320.69B |
| JETEMA, | 75.55B |
| Helixmith | 3.74B |
| Green Cross Holdings | 2,397.09B |